New Cancer Treatments
Brain Cancer
New tumor-targeting agents (APC) able to seek out and find solid tumors, even illuminating brain cancer stem cells that resist current treatments
Science Daily
June, 2014
http://www.sciencedaily.com/releases/2014/06/140611143653.htm
Breast Cancer
Potentially powerful new way to treat HER2-positive breast cancer validated
May 25, 2014
http://www.medicalnewstoday.com/releases/276998.php
Cervical Cancer
Avastin approved for cervical cancer treatment by FDA
Headlines and Global News
August 17, 2014
http://www.hngn.com/articles/39349/20140817/avastin-approved-for-cervical-cancer-treatment-by-fda.htm
Colon Cancer
Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials
The Oncologist
September, 2013
Bevacizumab Efficacy and Safety in mCRC: Pooled Analysis
Pancreatic Cancer
Ruxolitinub combo improves outcomes in metastic pancreatic cancer
OncLive
June, 2014
http://www.onclive.com/conference-coverage/world-GI-2014/Ruxolitinib-Combo-Improves-Outcomes-in-Metastatic-Pancreatic-Cancer
Liver Cancer
Liver cancer vaccine results announced in Mongolia:
June 24, 2014
http://www.marketwatch.com/story/immunitors-breakthrough-in-cancer-immunotherapy-2014-06-25
Stomach Cancer
FDA approves Ramucirumab for stomach cancer
ASCO Post
May, 2014
http://www.ascopost.com/issues/may-15,-2014/fda-approves-ramucirumab-for-stomach-cancer.aspx
Esophageal Cancer
Using liquid nitrogen as a treatment for early esophageal cancer SunSentinel
July 8, 2014
http://www.google.com/search?client=safari&rls=en&q=esophageal+cancer&ie=UTF-8&oe=UTF-8#q=esophagea
Adrenal Cancer
Team uses nanoparticles to enhance chemotherapy; proceedings of the National Academy of Sciences
July 7, 2014
http://phys.org/news/2014-07-team-nanoparticles-chemotherapy.html
Thyroid Cancer
EMA approves Eisai’s Lenvatinib for accelerated assessment in radioiodine-refractory differentiated thyroid cancer
MarketWatch
July 31, 2014
http://www.marketwatch.com/story/ema-approves-eisais-lenvatinib-for-accelerated-assessment-in-radioiodine-refractory-differentiated-thyroid-cancer-2014-07-30
Bladder Cancer
Neoadjuvant chemotherapy beneficial in muscle-invasive bladder cancer
Clinical Oncology News
July, 2014
http://www.clinicaloncology.com/ViewArticle.aspx?d=Reviews+and+Commentaries&d_id=543&i=July+2014&i_id=1082&a_id=27734
Kidney Cancer
Sunitinib or Everolimus first-line for kidney cancer
Journal of Clinical Oncology
Medscape
July 24, 2014
http://www.medscape.com/viewarticle/828815
Prostate Cancer
Genetic test personalizes prostate cancer
DotMed
July 30, 2014
http://www.dotmed.com/news/story/23943?utm_source=news&utm_medium=rss&utm_campaign=generic
Head and Neck Cancer
The US Food and Drug Administration have given the OK for doctors to use Lymphoseek – a radioactive diagnostic imaging agent – to evaluate the spread of squamous cell carcinoma in the body’s head and neck region.
http://www.medicalnewstoday.com/articles/278302.php
Leukemia
FDA expands approved use of Imbruvica for chronic lymphocytic leukemia
FDA News Release
July 28, 2014
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm406916.htm
FDA approves Idelalisib for three leukemia and lymphoma indications
The Oncology Report
July 23, 2014
http://www.oncologypractice.com/oncologyreport/home/article/fda-approves-idelalisib-for-three-leukemia-and-lymphoma-indications/1e0c726a08e9781744ddd696e94b58ce.html
Lymphomas
Lymphoma drug gets trio of FDA approvals
Med Page Today
July 23, 2014
http://www.medpagetoday.com/PublicHealthPolicy/FDAGeneral/46902
Multiple Myeloma
Lenalidomide for multiple myeloma
The Pharaceutical Journal
August 1, 2014
http://www.pharmaceutical-journal.com/news-and-analysis/notice-board/lenalidomide-for-multiple-myeloma/20066049.article
Lung Cancer
Afatinib plus cetuximab shows promise in EGRF-mutated lung cancer HemOnc Today
July 31, 2014
http://www.healio.com/hematology-oncology/lung-cancer/news/online/%7B71099a79-b4ea-477b-8d6b-941b9fcba816%7D/afatinib-plus-cetuximab-shows-promise-for-egfr–mutated-lung-cancer
Melanoma
Pembrolizumab works in melanoma after Ipilimumab
Medscape
July 23, 2014
http://www.medscape.com/viewarticle/828738
Brain Cancer
Journal of Clinical Cancer Research; Low Dose of Targeted Drug (bortezomib) might improve cancer-killing virus therapy
Science Daily
June 16, 2014
http://www.sciencedaily.com/releases/2014/06/140616204544.htm
Colon Cancer
First line therapy approved for Stage IV Colon Cancer
June 16, 2014
http://fightcolorectalcancer.org/first-line-treatment-approved-for-stage-iv-colorectal-cancer/
Stomach Cancer
FDA Approves Ramucirumab for Stomach Cancer ASCO Post May, 2014 http://www.ascopost.com/issues/may-15,-2014/fda-approves-ramucirumab-for-stomach-cancer.aspx
Thyroid Cancer
EMA Approves Eisai’s Lenvatinib for Accelerated Assessment in Radioiodine-Refractory Differentiated Thyroid Cancer
MarketWatch
July 31, 2014
http://www.marketwatch.com/story/ema-approves-eisais-lenvatinib-for-accelerated-assessment-in-radioiodine-refractory-differentiated-thyroid-cancer-2014-07-30
Leukemia
Novartis Wins ‘Breakthrough’ Status for New Leukemia treatment
The Wall Street Journal
July 7, 2014
http://online.wsj.com/articles/novartis-wins-breakthrough-status-for-new-leukemia-treatment-1404758105
Lymphoma
Lymphoma Drug Gets Trio of FDA Approvals
Med Page Today
July 23, 2014
http://www.medpagetoday.com/PublicHealthPolicy/FDAGeneral/46902